Literature DB >> 12579619

Erotomanic stalking in evolutionary perspective.

Martin Brüne1.   

Abstract

Erotomania, the delusion of being loved by another person, comprises marked sex differences concerning prevalence rates and behavior. Whereas traditional psychiatry has considered erotomania to be almost entirely restricted to women, recent studies have revealed that criminal offenses associated with the condition occur much more frequently in men. The main hypothesis of this article is that these findings may be explained in terms of evolutionary theory. Erotomania, accordingly, may be viewed as a pathological variant of a specific sexual strategy that evolved under selection pressures of the human environment of evolutionary adaptedness. The overt behavior is related to the pursuit of long-term mating, its potentially beneficial effect on inclusive fitness of the individual, and disparate strategies of the sexes to ensure sexual fidelity of the potential partner. Therefore, the evolutionary approach provides a plausible explanation as to why forensically relevant erotomania prevails in men. The pathological process of delusional misinterpretation of perceived signals from the social environment itself may result from poor reality testing due to a failure of social meta-cognition. The evolutionary perspective may provide additional insights into the nature of sex-specific behaviors and may improve our understanding of forensically relevant behaviors. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12579619     DOI: 10.1002/bsl.518

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  2 in total

Review 1.  Erotomania : epidemiology and management.

Authors:  Brendan D Kelly
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  De Clérambault's syndrome revisited: a case report of Erotomania in a male.

Authors:  Maria Teresa Tavares Rodrigues Tomaz Valadas; Lucilia Eduarda Abrantes Bravo
Journal:  BMC Psychiatry       Date:  2020-10-23       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.